KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Intangibles (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Change in Intangibles for 13 consecutive years, with $19.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Intangibles rose 99.51% year-over-year to $19.2 million, compared with a TTM value of $58.2 million through Dec 2025, up 60.6%, and an annual FY2025 reading of $58.2 million, up 60.6% over the prior year.
  • Change in Intangibles was $19.2 million for Q4 2025 at Travere Therapeutics, up from $15.0 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $23.0 million in Q1 2023 and bottomed at $3.8 million in Q2 2023.
  • Average Change in Intangibles over 5 years is $9.0 million, with a median of $7.0 million recorded in 2022.
  • The sharpest move saw Change in Intangibles surged 347.82% in 2023, then tumbled 71.89% in 2024.
  • Year by year, Change in Intangibles stood at $5.0 million in 2021, then dropped by 17.42% to $4.2 million in 2022, then soared by 32.11% to $5.5 million in 2023, then surged by 75.17% to $9.6 million in 2024, then skyrocketed by 99.51% to $19.2 million in 2025.
  • Business Quant data shows Change in Intangibles for TVTX at $19.2 million in Q4 2025, $15.0 million in Q3 2025, and $12.1 million in Q2 2025.